(Q37542134)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19580182%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

review article

1 reference

title

COX-2, VEGF and tumour angiogenesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19580182%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

1 reference

D P Toomey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19580182%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

J F Murphy

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19580182%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

K C Conlon

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19580182%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

1 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19580182%20AND%20SRC:MED&resulttype=core&format=json

Journal of the Royal College of Surgeons of Edinburgh

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19580182%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19580182%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19580182%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

174-180

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19580182%20AND%20SRC:MED&resulttype=core&format=json

Vascular endothelial growth factor induces cyclooxygenase-dependent proliferation of endothelial cells via the VEGF-2 receptor

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Inhibition of tumor angiogenesis by non-steroidal anti-inflammatory drugs: emerging mechanisms and therapeutic perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

The relationship between cyclooxygenase-2 expression and colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Fishing for prostanoids: deciphering the developmental functions of cyclooxygenase-derived prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Prostaglandins and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Correlation between cyclooxygenase-2 and tumor angiogenesis in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Cyclooxygenase-2 expression in human pancreatic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Host cyclooxygenase-2 modulates carcinoma growth.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

The selective cyclooxygenase-2 inhibitor nimesulide induces apoptosis in pancreatic cancer cells independent of COX-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Targeting cyclooxygenase-2 in human neoplasia: rationale and promise

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Mechanisms of disease: Inflammatory mediators and cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

COX-2: a molecular target for colorectal cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Mechanisms for the prevention of gastrointestinal cancer: the role of prostaglandin E2.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Prostanoids, ornithine decarboxylase, and polyamines in primary chemoprevention of familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Angiogenesis--a new target for future therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

VEGF receptor signaling in tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF).

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Vascular-specific growth factors and blood vessel formation

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Hypoxia and angiogenesis in pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

von Hippel-Lindau syndrome: target for anti-vascular endothelial growth factor (VEGF) receptor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

VEGF as a key mediator of angiogenesis in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Pro-angiogenic cytokines and their role in tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Tumor angiogenesis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Angiogenesis in cancer and other diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Cyclooxygenase 2-derived prostaglandin E2 regulates the angiogenic switch

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor-associated angiogenesis and growth in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

PGE(2) is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Up-regulation of the enzymes involved in prostacyclin synthesis via Ras induces vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Cyclooxygenase-2 inhibitors suppress angiogenesis and growth of gastric cancer xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Engagement of CD44 modulates cyclooxygenase induction, VEGF generation, and proliferation in human vascular endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Induction of cyclooxygenase-1 and -2 modulates angiogenic responses to engagement of alphavbeta3.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

Vascular endothelial growth factor (VEGF)-A165-induced prostacyclin synthesis requires the activation of VEGF receptor-1 and -2 heterodimer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2809%2980042-5

7 January 2021

10.1016/S1479-666X(09)80042-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19580182%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference